Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience

被引：12
|
作者：
Cerchione, Claudio [1 ]
Catalano, Lucio [1 ]
Pareto, Anna Emanuele [1 ]
Picardi, Marco [1 ]
Pane, Fabrizio [1 ]
机构：
[1] Hematol AOU Federico II, Naples, Italy
来源：
SUPPORTIVE CARE IN CANCER | 2015年 / 23卷 / 02期
关键词：
Bortezomib; Febrile Neutropenia; Lenalidomide; National Comprehensive Cancer Network; National Comprehensive Cancer Network;
D O I：
10.1007/s00520-014-2490-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：301 / +
页数：2
相关论文
共 50 条
  • [41] Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
    Claudio Cerchione
    Lucio Catalano
    Ilaria Peluso
    Davide Nappi
    Maria Di Perna
    Dalila Salvatore
    Ilaria Migliaccio
    Marco Picardi
    Fabrizio Pane
    Supportive Care in Cancer, 2016, 24 : 4835 - 4837
  • [42] Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience
    Canto, Chiara
    Ranucci, Elena
    Pulini, Stefano
    Santoleri, Fiorenzo
    Morelli, Anna Maria
    Fioritoni, Francesca
    Falorio, Simona
    Torti, Lorenza
    Spadano, Antonio
    D'Aloisio, Marianna
    Di Ianni, Mauro
    Santarone, Stella
    Di Bartolomeo, Paolo
    BLOOD, 2018, 132
  • [43] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL- LIFE EXPERIENCE
    Cerchione, C.
    Zacheo, I
    Di, Perna M.
    Nappi, D.
    Pareto, A. E.
    Peluso, I
    Ferrara, K.
    Pane, F.
    Catalano, l
    HAEMATOLOGICA, 2018, 103 : 39 - 40
  • [44] EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE
    Soyer, N.
    Patir, P.
    Uysal, A.
    Duran, M.
    Unal, H. D.
    Tombuloglu, M.
    Sahin, F.
    Vural, F.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S36 - S36
  • [45] Real world experience with "generic" pomalidomide in relapsed refractory multiple myeloma
    Jandial, Aditya
    Mishra, Kundan
    Lad, Deepesh
    Prakash, Gaurav
    Khadwal, Alka
    Malhotra, Pankaj
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1102 - 1104
  • [46] NIVOLUMAB FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A REAL-LIFE EXPERIENCE IN CAMPANIA
    Trastulli, F.
    Vitagliano, O.
    Della Pepa, R.
    Giordano, C.
    Rosamilio, R.
    Pezzullo, L.
    Ronconi, F.
    Ferrara, F.
    Pane, F.
    Picardi, M.
    HAEMATOLOGICA, 2019, 104 : 129 - 129
  • [47] Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study
    Del Giudice, Maria Livia
    Gozzetti, Alessandro
    Antonioli, Elisabetta
    Orciuolo, Enrico
    Ghio, Francesco
    Ciofini, Sara
    Candi, Veronica
    Fontanelli, Giulia
    Attucci, Irene
    Formica, Giuseppe
    Bocchia, Monica
    Galimberti, Sara
    Petrini, Mario
    Buda, Gabriele
    MEDICINA-LITHUANIA, 2021, 57 (09):
  • [48] Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience
    Antonioli, Elisabetta
    Staderini, Michela
    Pilerci, Sofia
    Perfetto, Federico
    Cappelli, Francesco
    Allinovi, Marco
    Nozzoli, Chiara
    Attucci, Irene
    Buzzichelli, Alessandra
    Messeri, Maria
    Bosi, Alberto
    LEUKEMIA & LYMPHOMA, 2020, 61 (13) : 3255 - 3258
  • [49] “Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience
    I. Vaxman
    J. Abeykoon
    A. Dispenzieri
    S. K. Kumar
    F. Buadi
    M. Q. Lacy
    D. Dingli
    Y. Hwa
    A. Fonder
    M. Hobbs
    C. Reeder
    T. Sher
    S. Hayman
    T. Kourelis
    R. Warsame
    E. Muchtar
    N. Leung
    R. Go
    W. Gonsalves
    M. Siddiqui
    R. A. Kyle
    S. V. Rajkumar
    McCullough Kristen
    P. Kapoor
    M. A. Gertz
    Blood Cancer Journal, 11
  • [50] PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF THERAPY RELATED NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN TREATMENT WITH POMALIDOMIDE-DEXAMETHASONE
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Picardi, M.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S129 - S129
12345